A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Study of SCIO-469 in Patients in Active Rheumatoid Arthritis Receiving Methotrexate
Phase of Trial: Phase II
Latest Information Update: 12 Feb 2008
At a glance
- Drugs Talmapimod (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 28 Oct 2005 New trial record.